Aug 2026
Comparison of the Prognostic Value of PET Metabolic Parameters and Postoperative Pathologic Response After Neoadjuvant Immunochemotherapy in Non-Small Cell Lung Cancer.
The combination of serial PET metabolic parameters and postoperative pathologic response in a joint model improves prognostic prediction in NSCLC following neoadjuvant immunotherapy plus chemotherapy.
You Cheng, Tian Qin, Fan Yang et al.
· Clinical Nuclear Medicine · 0 citations